These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 32378605)

  • 41. A comparison of oncological outcomes between transoral surgical and non-surgical treatment protocols in the management of oropharyngeal squamous cell carcinoma.
    Kao SS; Micklem J; Ofo E; Edwards S; Dhatrak D; Foreman A; Krishnan S; Hodge JC
    J Laryngol Otol; 2018 Apr; 132(4):349-355. PubMed ID: 28480836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation.
    Gorphe P; Chekkoury Idrissi Y; Tao Y; Schernberg A; Ou D; Temam S; Casiraghi O; Blanchard P; Mirghani H
    Papillomavirus Res; 2018 Jun; 5():32-37. PubMed ID: 29253748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
    Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
    Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Oliva M; Huang SH; Xu W; Su J; Hansen AR; Bratman SV; Ringash J; Jang R; Cho J; Bayley A; Hope AJ; Chen E; Giuliani M; Waldron J; Weinreb I; Perez-Ordonez B; Chepeha D; Kim J; O Sullivan B; Siu LL; Spreafico A
    Eur J Cancer; 2019 Sep; 118():112-120. PubMed ID: 31330486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of human papilloma virus in patients with oral and oropharyngeal squamous cell carcinomas.
    Valls-Ontañón A; Hernández-Losa J; Somoza Lopez de Haro R; Bellosillo-Paricio B; Ramón Y Cajal S; Bescós-Atín C; Munill-Ferrer M; Alberola-Ferranti M
    Med Clin (Barc); 2019 Mar; 152(5):174-180. PubMed ID: 30777194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p16 status and interval neck dissection findings after a 'clinically complete response' to chemoradiotherapy in oropharyngeal squamous cell carcinoma.
    Miah MS; Spielmann P; White SJ; Kennedy C; Kernohan N; Mountain RE; Cassasola R; Mahendran S
    J Laryngol Otol; 2015 Aug; 129(8):801-6. PubMed ID: 26087671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytomorphologic diagnosis and HPV testing of metastatic and primary oropharyngeal squamous cell carcinomas: a review and summary of the literature.
    Jarboe EA; Hunt JP; Layfield LJ
    Diagn Cytopathol; 2012 Jun; 40(6):491-7. PubMed ID: 22351436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction chemotherapy followed by concurrent chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma with HPV and P16 testing.
    Flavill E; Fang YV; Miles B; Truelson J; Perkins S
    Ann Otol Rhinol Laryngol; 2014 May; 123(5):365-73. PubMed ID: 24687594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
    Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
    Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
    Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
    Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
    Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].
    Huang H; Zhang B; Chen W; Zou SM; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):684-8. PubMed ID: 24332056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Tumor Size and p16 Status on Treatment Outcomes - Achievement of Complete Remission in Prospectively Followed Patients with Oropharyngeal Tumors.
    Slavik M; Kazda T; Selingerová I; Šána J; Ahmad P; Gurín D; Hermanová M; Novotný T; Červená R; Dymáčková R; Burkoň P; Slabý O; Šlampa P
    Klin Onkol; 2019; 32(1):58-65. PubMed ID: 30764631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
    Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.
    Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T
    ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
    Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
    Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
    Lassen P; Lacas B; Pignon JP; Trotti A; Zackrisson B; Zhang Q; Overgaard J; Blanchard P;
    Radiother Oncol; 2018 Jan; 126(1):107-115. PubMed ID: 29100700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.